Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
BGMD > SEC Filings for BGMD > Form 8-K on 5-Jun-2014All Recent SEC Filings

Show all filings for BG MEDICINE, INC.

Form 8-K for BG MEDICINE, INC.


5-Jun-2014

Submission of Matters to a Vote of Security Holders


Item 5.07. Submission of Matters to a Vote of Security Holders.

(a) On June 3, 2014, the Company held its 2014 Annual Meeting of Stockholders (the "Annual Meeting"). Of 27,937,062 shares of common stock issued and outstanding and eligible to vote as of the record date of April 7, 2014, a quorum of 22,948,644 shares, or 82.1% of the eligible shares, was present in person or represented by proxy.

(b) The following actions were taken at the Annual Meeting:

1. The following nominees were reelected to serve on the Company's Board of Directors (the "Board") as Class III Directors until the Company's 2017 annual meeting of stockholders and until their successors are duly elected and qualified, based on the following votes:

                                                    Withheld          Broker
           Nominee                 Voted For        Authority        Non-Vote
           Stéphane Bancel          12,410,725          76,820       10,461,099
           Paul R. Sohmer, M.D.     12,418,406          69,139       10,461,099

After the Annual Meeting, Noubar Afeyan, Ph.D., Stelios Papadopoulos, Ph.D., and Harrison M. Bains, continued to serve as Class I Directors for terms that expire at the 2015 annual meeting and until their successors are duly elected and qualified, and Timothy Harris, Ph.D., D.Sc. and Brian Posner continued to serve as Class II Directors for terms that expire at the 2016 annual meeting and until their successors are duly elected and qualified.

2. The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014 was ratified, based on the following votes:

22,678,474 votes FOR; 43,599 votes AGAINST; 226,571 votes ABSTAINING and no broker non-votes.

3. The compensation of the Company's named executive officers as disclosed in the proxy statement for the Annual Meeting was approved, on an advisory basis, based on the following votes:

12,340,008 votes FOR; 128,821 votes AGAINST; 18,716 votes ABSTAINING and 10,461,099 broker non-votes.


  Add BGMD to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for BGMD - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.